MedTrace Logo

Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis

NCT01795456 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2017-01-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the ability of contrast enhanced carotid ultrasound to serve as an indicator of disease activity in patients with Takayasu's arteritis or Giant Cell arteritis and to determine if patients with active arteritis have a thickening of their blood vessel walls compared to healthy people of the same age and gender.

Conditions

  • Takayasu's Arteritis
  • Giant Cell Arteritis
  • Arteritis
  • Vasculitis
  • Aortitis

Sponsors & Collaborators

  • GE Healthcare

    collaborator INDUSTRY

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Soo Hyun Kim, MD, MPH · The Cleveland Clinic

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01795456 on ClinicalTrials.gov